Highlights and Quick Summary
- Net Profit Margin for the quarter ending December 31, 2022 was 89.62% (a -82.85% decrease compared to previous quarter)
- Year-over-year quarterly Net Profit Margin decreased by -249.07%
- Annual Net Profit Margin for 2022 was 105.23% (a -116.29% decrease from previous year)
- Annual Net Profit Margin for 2021 was -646.01% (a 21.2% increase from previous year)
- Annual Net Profit Margin for 2020 was -533.01% (a 50.02% increase from previous year)
- Twelve month Net Profit Margin ending December 31, 2022 was 105.23% (a 41.61% increase compared to previous quarter)
- Twelve month trailing Net Profit Margin decreased by -124.35% year-over-year
Trailing Net Profit Margin for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| 105.23% | 74.31% | -439.25% | -432.1% |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Profit Margin of Precigen, Inc.
Most recent Net Profit Marginof PGEN including historical data for past 10 years.Interactive Chart of Net Profit Margin of Precigen, Inc.
Precigen, Inc. Net Profit Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 89.62% | 522.54% | -605.81% | -60.12% | 105.23% |
| 2021 | 143.94% | -893.01% | -525.56% | -70.65% | -646.01% |
| 2020 | 80.34% | -125.12% | -142.5% | -187.67% | -533.01% |
| 2019 | -995.27% | -293.1% | -118.06% | -268.8% | -355.29% |
| 2018 | -1007.62% | -176.66% | -144.41% | -116.38% | -336.91% |
| 2017 | -41.78% | -86.25% | -34.29% | -58.42% | -53.32% |
| 2016 | -95.95% | -59.17% | -93.45% | -148.32% | -97.74% |
| 2015 | -78.83% | -71.6% | -90.58% | 80.05% | -48.67% |
| 2014 | 60.57% | -248.74% | -441.53% | 52.39% | -113.75% |
| 2013 | -127.01% | 137.74% | -207.85% | -1099.51% | -241.46% |
| 2012 | -887.49% | -803.26% | – | – | -754.09% |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology